Neurology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text (PDF)
Right arrow Correspondence:
Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when Correspondence are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kono, N.
Right arrow Articles by Tarui, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kono, N.
Right arrow Articles by Tarui, S.
NEUROLOGY 1984;34:1471
© 1984 American Academy of Neurology

Metabolic basis of improved exercise tolerance

Muscle phosphorylase deficiency after glucagon administration

Norio Kono, Ikuo Mineo, Seiichi Sumi, Takao Shimizu, Jin Kang, Kyohei Nonaka and Seiichiro Tarui

From the Second Department of Internal Medicine, Osaka University Medical School, Fukushima-ku, Osaka, and the Department of Neurology (Dr. Kang), National Toneyama Hospital, Toneyama, Toyonaka, Japan.

A 26-year-old girl with muscle phosphorylase deficiency had exercise intolerance and experienced an occasional "second wind" phenomenon. Muscle glycogen concentration was about three times the normal level, whereas each glycolytic intermediate below the phosphorylase step was equivalent to only 10% of a normal level. Semi-ischemic forearm exercise tests disclosed no elevation of the venous lactate or pyruvate level, but they showed remarkable increases of serum creatine kinase and ammonia. Glucagon administration markedly augmented exercise tolerance. Forearm exercise after glucagon injection significantly increased venous lactate. Thus, the beneficial effect of glucagon is attributable to blood glucose utilization by muscle.

Address correspondence and reprint requests to Dr. Kono, The Second Department of Internal Medicine, Osaka University Medical School, Fukushima-ku, Osaka, Japan 553.

Supported in part by Grants-in-Aid for Scientific Research (nos. 544085, 557548, 57480399, 57480400, 59480214, and 59870040) and for Special Project Research (nos. 56120009.57113009, and 58105008) from the Ministry of Education, Science and Culture of Japan; Grant (no. 82-39) from NCNMMD of the Ministry of Health and Welfare of Japan; and Basic Research Grant from the Muscular Dystrophy Association of the United States.

Accepted for publication March 8, 1984.




This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
H. Fukui, S.-i. Taniguchi, Y. Ueta, A. Yoshida, A. Ohtahara, I. Hisatome, and C. Shigemasa
Enhanced Activity of the Purine Nucleotide Cycle of the Exercising Muscle in Patients with Hyperthyroidism
J. Clin. Endocrinol. Metab., May 1, 2001; 86(5): 2205 - 2210.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
S. Baqué, J. J. Guinovart, and A. M. Gómez-Foix
Overexpression of Muscle Glycogen Phosphorylase in Cultured Human Muscle Fibers Causes Increased Glucose Consumption and Nonoxidative Disposal
J. Biol. Chem., February 2, 1996; 271(5): 2594 - 2598.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1984 by AAN Enterprises, Inc.